Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-95

Hear hear abdm...

The ignorance and misunderstanding of biotech and medical products in oz is mind boggling... my broker even last year called ahz a biotech start up! I had to correct him.

The animal and clinical test tube trials were extremely succesful, some biotechs in the US would go nuts with these sorts of results but here in sleepy hollow the kid traders look for momentum moves, they dont care about potential, future results, they want to eee cashflow and profits not intellectualism and brow beating by medical experts who they think are out of touch academics for whom they have no respect.

These brokers dont have 5 year degrees try 6 month courses if that..they dont get hsv or hpv or the skin cancer vaccine pr rraser announced he was working on twitter nor the nano patch nor the leading edge adapt tissue as a stem cell delivery platform let alone CC and its ever growing global bodywide applications.

I Say CC is a monster..its unstoppable, its application and sales growth unlimited for the next 5 years, will the oz market get it or do the overseas interests get I n cheap again. its a shame that the tail wags the dog.